Ameed Bawwab

Ameed Bawwab

Auto-generated profile, based on publicly available information

Ameed Bawwab

Department of Internal Medicine, Cleveland Clinic Mercy Hospital, Canton, Ohio, USA, clevelandclinic.org

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
ABAmeed Bawwab
Ameed Bawwab
EZEmily C. Zabor
Emily C. Zabor
LKLana Khatib
Lana Khatib
MAMoath Albliwi
Moath Albliwi
JHJohn Hanna
John Hanna
MAMoaath Mustafa Ali
Moaath Mustafa Ali
Background: The prognostic significance of the proportion of normal metaphases detected at diagnosis in acute myeloid leukemia (AML) has not been systematically evaluated. Methods: We conducted a retrospective cohort study of 893 adult AML patients treated at Cleveland Clinic between 01/2015-09/2023 who underwent conventional cytogenetic analysis. Normal karyotype fraction (NKF) was defined as the proportion of normal metaphases among all metaphases analyzed at diagnosis. NKF was evaluated as a continuous measure and categorized using three-group (NKF = 0, 0 < NKF < 1, NKF = 1) and five-group functional classification systems. Primary outcomes included overall survival (OS), event-free survival (EFS), composite complete remission (CR/CRi), and relapse. Multivariable Cox proportional hazards and logistic regression models were adjusted for established prognostic covariates. Results: NKF demonstrated a bimodal distribution across the cohort. Patients with NKF = 1 achieved the highest CR/CRi rate (64%) and longest median OS (16 months) and EFS (11 months). In multivariable analyses, NKF = 1 was independently associated with improved OS (HR 0.77, 95%CI 0.61-0.97) and EFS (HR 0.72, 95%CI 0.58-0.90), and higher odds of achieving CR/CRi (OR 1.72, 95%CI 1.10-2.70) compared with NKF = 0. EFS was significantly associated with NKF categories in both classification systems (p <0.05). Conclusion: NKF is a novel, readily obtainable prognostic parameter derived from routine cytogenetics that independently predicts treatment response and survival in AML. External validation and prospective studies are warranted to support its use in clinical risk stratification frameworks.

12 August 2026 in Clinical Lymphoma Myeloma and Leukemia
Verified
Journal Article
Open access
ABAmeed Bawwab
Ameed Bawwab
EZEmily C. Zabor
Emily C. Zabor
LKLana Khatib
Lana Khatib
MAMoath Albliwi
Moath Albliwi
JHJohn Hanna
John Hanna
MAMoaath Mustafa Ali
Moaath Mustafa Ali

16 January 2026 in Case Reports in Oncological Medicine
Verified
Journal Article
Open access
ABAmeed Bawwab
Ameed Bawwab
LKLana Khatib
Lana Khatib
MAMoath Ahmad Salman Albliwi
Moath Ahmad Salman Albliwi
LYLinlin Yang
Linlin Yang
PZPei Jun Zhao
Pei Jun Zhao
Diffuse large B‐cell lymphoma (DLBCL) is an aggressive malignancy and the most common subtype of non‐Hodgkin lymphoma, typically presenting with lymphadenopathy. Pericardial involvement is extremely rare. We report the case of a patient who presented with cough and shortness of breath and was admitted for acute hypoxic respiratory failure. During hospitalization, the patient developed atrial fibrillation with rapid ventricular response (RVR). Transthoracic echocardiography revealed a pericardial effusion, which increased in size on repeat imaging 1 week later. The patient subsequently underwent pericardiocentesis, and cytology of the pericardial fluid confirmed DLBCL, with the pericardium identified as the primary site of involvement. The patient was treated with mini‐R‐CHOP chemotherapy, resulting in marked clinical improvement.